Pediatric experts from Le Bonheur’s Heart Institute and the University of Tennessee Health Science Center will present lectures, posters, abstracts and hands-on workshops. Pediatric experts from Le ...
Credit: Getty Images. Evidence suggests that patent ductus arteriosus comprises anywhere from 5% to 10% of all congenital heart disease. Although the majority of congenital heart diseases (CHD) are ...
Ibuprofen again failed to improve short-term outcomes when used to close patent ductus arteriosus (PDA) in newborns, the placebo-controlled Baby-OSCAR trial showed. Administered parenterally a few ...
Merit Medical Systems initiates a study to evaluate the Bloom Micro Occluder System for treating patent ductus arteriosus in premature infants. Merit Medical Systems, Inc. has announced the enrollment ...
Miami-based Nicklaus Children’s Heart Institute is now performing bedside transcatheter patent ductus arteriosus (PDA) closures for newborns. The minimally invasive procedure is done directly in the ...
During this tenure, he was instrumental in strengthening the Pediatric Cardiology and Interventional Cardiology Program and also launched the International PDA Symposium in 2018, the first ...
“This position statement represents a collective effort between neonatology, anesthesia, and interventional cardiology to provide comprehensive guidance on tcPDA device occlusion that can be adapted ...
An FDA alert warned of problems with some Mobile Power Units of the HeartMate II and HeartMate 3 left ventricular assist devices. Medtronic's thin OmniaSecure defibrillation lead got FDA approval for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback